azd2563 has been researched along with Pulmonary Consumption in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balasubramanian, V; Hoffner, S; Perskvist, N; Rodrigues, C; Sambandamurthy, VK; Werngren, J; Wijkander, M | 1 |
| Balasubramanian, V; Bharath, S; Butler, SL; Deshpande, A; Gaonkar, S; Kumar, N; Mahesh, KN; Melnick, D; Reddy, J; Shandil, R; Solapure, S; Wright, L | 1 |
| Betoudji, F; Converse, PJ; Dartois, V; Li, SY; Mdluli, KE; Mendel, CM; Nuermberger, EL; Tasneen, R; Tyagi, S; Williams, K; Yang, T | 1 |
3 other study(ies) available for azd2563 and Pulmonary Consumption
| Article | Year |
|---|---|
In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
Pharmacokinetic and pharmacodynamic evaluation of AZD5847 in a mouse model of tuberculosis.
Topics: Animals; Area Under Curve; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary | 2014 |
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis.
Topics: Animals; Antitubercular Agents; Bacterial Load; Diarylquinolines; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Female; Linezolid; Lung; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Nitroimidazoles; Organophosphates; Oxazoles; Oxazolidinones; Pyrazinamide; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary | 2016 |